Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $345.03 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $153.40 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $139.24 | 8 | $0 (2024) |
| Grifols USA, LLC | $24.63 | 1 | $0 (2023) |
| Gilead Sciences, Inc. | $14.38 | 1 | $0 (2022) |
| Inari Medical, Inc. | $13.38 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.78 | 4 | ABBVIE INC. ($49.78) |
| 2023 | $123.21 | 7 | ABBVIE INC. ($60.70) |
| 2022 | $97.53 | 7 | Janssen Pharmaceuticals, Inc ($42.08) |
| 2021 | $39.51 | 3 | Janssen Pharmaceuticals, Inc ($24.28) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/09/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/21/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/22/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/19/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/15/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2023 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Immunology | ||||||
| 01/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/13/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: VTE | ||||||
| 06/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/11/2022 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: COVID-19 | ||||||
| 05/06/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/16/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/09/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 81 | 81 | $30,171 | $8,386 |
| 2022 | 3 | 74 | 74 | $22,595 | $6,815 |
| 2021 | 4 | 104 | 108 | $27,411 | $8,540 |
| 2020 | 10 | 264 | 410 | $62,662 | $15,172 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 46 | 46 | $20,056 | $6,083 | 30.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 35 | 35 | $10,115 | $2,303 | 22.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 27 | 27 | $11,520 | $3,957 | 34.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 24 | 24 | $6,846 | $1,877 | 27.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 23 | 23 | $4,229 | $980.87 | 23.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 45 | 46 | $12,494 | $3,805 | 30.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 22 | 22 | $8,990 | $3,322 | 37.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 18 | 21 | $3,678 | $975.00 | 26.5% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 19 | 19 | $2,249 | $437.47 | 19.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 43 | 45 | $17,100 | $5,824 | 34.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 41 | 42 | $10,584 | $3,501 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 59 | $11,800 | $3,029 | 25.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 21 | 21 | $3,423 | $937.46 | 27.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 16 | 16 | $3,600 | $708.63 | 19.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 16 | 18 | $4,680 | $584.84 | 12.5% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 12 | 12 | $1,332 | $366.71 | 27.5% |
| 73562 | X-ray of knee, 3 views | Office | 2020 | 28 | 30 | $3,534 | $146.51 | 4.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2020 | 12 | 13 | $1,989 | $60.65 | 3.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 17 | 154 | $4,620 | $12.76 | 0.3% |
About Britney Arnold, PA-C
Britney Arnold, PA-C is a Physician Assistant healthcare provider based in Carbondale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/10/2013. The National Provider Identifier (NPI) number assigned to this provider is 1013342039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Britney Arnold, PA-C has received a total of $345.03 in payments from pharmaceutical and medical device companies, with $84.78 received in 2024. These payments were reported across 21 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($345.03).
As a Medicare-enrolled provider, Arnold has provided services to 523 Medicare beneficiaries, totaling 673 services with total Medicare billing of $38,913. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Carbondale, IL
- Active Since 09/10/2013
- Last Updated 10/28/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1013342039
Products in Payments
- XARELTO (Drug) $139.24
- DALVANCE (Drug) $109.36
- TEFLARO (Drug) $44.04
- HyperRAB (Biological) $24.63
- Veklury (Drug) $14.38
- FLOWTRIEVER CATHETER, S (Device) $13.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Carbondale
Tommie Smith, Pa-C, PA-C
Physician Assistant — Payments: $7,012
Mr. Kenneth Bannon, Bspa-C, BSPA-C
Physician Assistant — Payments: $5,280
Mrs. Rachel Sargent, Pa-C, PA-C
Physician Assistant — Payments: $3,299
Corrie Farris, Pa-C, PA-C
Physician Assistant — Payments: $2,522
Hannah Palmer, Pa, PA
Physician Assistant — Payments: $2,462
Christina Trapp
Physician Assistant — Payments: $2,419